| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 780719-70-2 | 5-Methyl-1,2,3,4-benzenetetramine | C7H12N4 |
| 780721-23-5 | Methyl hydrogen (2-amino-5-methyl-3-cyclohexen-1-yl)phosphonate | C8H16NO3P |
| 780721-73-5 | 4-Bromo-3-fluorobenzenecarboximidamide | C7H6BrFN2 |
| 780721-77-9 | 2,4-Dimethyl-5-(2-phenylethyl)-1H-imidazole | C13H16N2 |
| 780722-28-3 | Methyl 5-amino-2-fluoro-4-oxopentanoate | C6H10FNO3 |
| 780722-30-7 | 2-(Chloromethyl)-1-ethyl-1H-imidazole | C6H9ClN2 |
| 780722-77-2 | 5-Hydroxy-3-(6-hydroxy-5-methyl-3,6-dihydro-2H-pyran-2-yl)-2(5H)-furanone | C10H12O5 |
| 780723-20-8 | [2-(Dimethylamino)-4-pyridinyl]methanethiol | C8H12N2S |
| 780724-15-4 | Methyl (1R,2R)-2-amino-3-cyclohexene-1-carboxylate | C8H13NO2 |
| 780725-65-7 | Methyl (2S,4Z)-2-amino-5-cyano-4-pentenoate | C7H10N2O2 |
| 780725-93-1 | 3-Methyl-6,7,8,9,10,12-hexahydroazepino[2,1-b]quinazoline | C14H18N2 |
| 780726-56-9 | (1S,4R)-4-Amino-3-oxo-1,2,3,4-tetrahydro-1-isoquinolinecarboxylic acid | C10H10N2O3 |
| 780726-61-6 | [(2Z)-2-(Cyanoimino)-1-pyrrolidinyl]acetic acid | C7H9N3O2 |
| 780727-47-1 | (2R,4S,6R)-4-(Dimethylamino)-6-methyltetrahydro-2H-pyran-2-ol | C8H17NO2 |
| 780728-19-0 | 2-(2-Chloro-6-Fluoro-Phenyl)-Acetamidine | C8H8ClFN2 |
| 780728-22-5 | Methyl 4-imino-1-methyl-2-(methylsulfanyl)-1,4-dihydro-5-pyrimidinecarboxylate | C8H11N3O2S |
| 780728-76-9 | (3S)-3-[(Aminooxy)methyl]quinuclidine | C8H16N2O |
| 780728-95-2 | N-(1H-Imidazol-4-ylmethyl)-N,2,3-trimethylaniline | C13H17N3 |
| 780731-89-7 | (2E)-2-(4-Ethylbenzylidene)hydrazinesulfonic acid | C9H12N2O3S |
| 780732-78-7 | (2R,4R)-2-Methyl-4-piperidinecarboxamide | C7H14N2O |
| 780732-86-7 | 3-Methyl-4-nitrobenzenecarbodithioic acid | C8H7NO2S2 |
| 780733-52-0 | N-[4-[[2-(Aminooxy)Ethyl]Amino]Butyl]-Acetamide | |
| 780734-82-9 | 4-Methyl-4,4a,5,6,7,7a-hexahydro-1H-cyclopenta[c]pyridin-3-amine | C9H16N2 |
| 780737-04-4 | Methyl 3-cyclopropyl-N-methyl-L-alaninate | C8H15NO2 |
| 780738-23-0 | 7-Bromo-6-methyl-1,2,3,4-tetrahydroisoquinoline | C10H12BrN |
| 780738-24-1 | (2S)-2-(cyclohexoxymethyl)pyrrolidine | C11H21NO |
| 780739-48-2 | 5-isobutyl-3-isopropyl-3-methyl-cyclohexanamine | C14H29N |
| 780739-71-1 | 1,2,3,4-Tetrahydro-6-nitro-3-isoquinolinecarboxylic acid | C10H10N2O4 |
| 780743-34-2 | 2-Amino-4,5,6,7-tetramethyl-1-indanone | C13H17NO |
| 780743-67-1 | (alphaR)-3,4,5-Trifluoro-alpha-Methyl-Benzenemethanamine | C8H8F3N |
| 780746-49-8 | 1-Methyl-5-(1H-pyrrol-1-yl)-1H-pyrazol-4-amine | C8H10N4 |
| 780747-61-7 | 1-(Aminomethyl)cyclobutanamine | C5H12N2 |
| 780749-63-5 | 2-Fluoro-5-(1H-imidazol-5-yl)pyridine | C8H6FN3 |
| 780749-95-3 | (R)-3-Amino-3-(3-Hydroxy-Phenyl)-Propionic Acid | |
| 780752-01-4 | 4-Amino-1-hydroxycyclohexanecarboxamide | C7H14N2O2 |
| 780753-59-5 | (5-Ethyl-4-methyl-1,3-thiazol-2-yl)sulfamic acid | C6H10N2O3S2 |
| 780753-89-1 | 1-(4-Fluorophenyl)-2-piperazinone | C10H11FN2O |
| 780754-27-0 | 5,6,7,8-Tetrahydro-5,8-Dimethyl-3-(Trifluoromethyl)-1,2,4-Triazolo[4,3-a]Pyrazine | |
| 780754-74-7 | 2-[2-(4-Methoxyphenyl)ethyl]-5-methyl-1H-pyrrole | C14H17NO |
| 780755-43-3 | 5-[(4-Methylphenyl)amino]-1,2,4-triazin-3(2H)-one | C10H10N4O |
| 780755-47-7 | 5-[(2,4-Dimethylphenyl)amino]-1,2,4-triazin-3(2H)-one | C11H12N4O |
| 780757-88-2 | ICG 001 | C33H32N4O4 |
| 780758-10-3 / 828933-51-3 | Nimotuzumab | |
| 780761-22-0 | (4b-Methyl-1,2,2a,2b,4a,4b-hexahydrocyclopropa[cd]pentalen-1-yl)methanol | C10H14O |
| 780761-23-1 | (4b-Methyl-1,2,2a,2b,4a,4b-hexahydrocyclopropa[cd]pentalen-2-yl)methanol | C10H14O |
| 780761-62-8 | 3-[(E)-1H-Imidazol-2-yldiazenyl]pyridine | C8H7N5 |
| 780761-64-0 | 3-[(E)-(1-Ethyl-1H-imidazol-2-yl)diazenyl]pyridine | C10H11N5 |
| 780763-66-8 | 2,4,5-Triazatricyclo[5.3.1.02,6]undeca-1(10),3,6,8-tetraene | C8H7N3 |
| 780763-92-0 | Methyl [4,6-dichloro-2-(4-nitrobenzyl)pyrimidin-5-yl]acetate | C14H11Cl2N3O4 |
| 780767-72-8 | 2-Amino-8,8-dimethyl-7-oxa-1-thia-3-azaspiro[4.4]non-2-ene-4,6-dione | C8H10N2O3S |